First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry

MLA

Galli, Luca, et al. “First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Real-World Italian Cohort of the Prostate Cancer Registry.” Tumori Journal, vol. 109, no. 2, Apr. 2023, pp. 224–32. EBSCOhost, https://doi.org/10.1177/03008916221079662.

APA

Galli, L., Chiuri, V. E., Di Lorenzo, G., Pisconti, S., Rossetti, S., Sirotova, Z., Muto, A., Petrioli, R., De Tursi, M., Sbrana, A., Francolini, G., Ardizzoia, A., Scavelli, C., Satta, F., Quadrini, S., Airoldi, M., D, A. C., Bonetti, A., Conforti, S., … Fratino, L. (2023). First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry. Tumori Journal, 109(2), 224–232. https://doi.org/10.1177/03008916221079662

Chicago

Galli, Luca, Vincenzo Emanuele Chiuri, Giuseppe Di Lorenzo, Salvatore Pisconti, Sabrina Rossetti, Zuzana Sirotova, Andrea Muto, et al. 2023. “First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Real-World Italian Cohort of the Prostate Cancer Registry.” Tumori Journal 109 (2): 224–32. doi:10.1177/03008916221079662.